Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients

Background: The global push for the use of hydroxychloroquine (HCQ) and chloroquine (CQ) against COVID-19 has resulted in an ongoing discussion about the effectivity and toxicity of these drugs. Recent studies report no effect of (H)CQ on 28-day mortality. We investigated the effect of HCQ and CQ in...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	A.J.J. Lammers, R.M. Brohet, R.E.P. Theunissen, C. Koster, R. Rood, D.W.M. Verhagen, K. Brinkman, R.J. Hassing, A. Dofferhoff, R. el Moussaoui, G. Hermanides, J. Ellerbroek, N. Bokhizzou, H. Visser, M. van den Berge, H. Bax, D.F. Postma, P.H.P. Groeneveld
פורמט:	Article
שפה:	English
יצא לאור:	Elsevier 2020-12-01
סדרה:	International Journal of Infectious Diseases
נושאים:	COVID-19 Hydroxychloroquine Chloroquine Azithromycin Clinical course
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S1201971220321755

אינטרנט

http://www.sciencedirect.com/science/article/pii/S1201971220321755

Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients

אינטרנט

פריטים דומים